MTM(SH:688029)2026-02-28 02:35Summary of Conference Call Transcript Company Overview - The company discussed is Nanwei Medical, which operates in the medical device industry, specifically focusing on products like hemostatic clips and microwave ablation needles. Key Financial Metrics - In 2025, the company achieved total revenue of 3.191 billion yuan, representing a growth of 15.81% [1] - The net profit attributable to shareholders was 570 million yuan, an increase of 3.05% [1] - The net profit excluding non-recurring items was 557 million yuan, up by 2.40% [1] - For Q4 2025, total revenue was 810 million yuan, reflecting a growth of 9.07% [2] - The net profit attributable to shareholders in Q4 was 61 million yuan, a decline of 40.42% [2] - The net profit excluding non-recurring items for Q4 was 49 million yuan, down by 49.78% [2] Core Insights and Arguments - The company experienced revenue growth despite a highly uncertain external environment and overall industry pressure, driven by overseas business and new product launches [1][2] - Domestic business remained stable, contributing to the overall revenue growth [2] - Strategies implemented included deepening localized marketing overseas, accelerating new product launches, and cost reduction measures to counteract the short-term pressures from centralized procurement and tariffs [2] Important but Overlooked Content - The decline in profit growth was attributed to several factors: 1. Decreased gross margins for key products due to centralized procurement [2] 2. A channel destocking strategy to respond to centralized procurement [2] 3. Increased expenses related to overseas investment projects, including preliminary research and intermediary services [2] 4. Fluctuations in the RMB exchange rate leading to certain foreign exchange losses [2]